Intervention strategy in elderly patient with atrial fibrillation and severe left atrial fibrosis

Authors: Stepanova N.M., Serguladze S.Yu., Sopov O.V., Aleksandrova S.A., Kvasha B.I.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Clinical Cases


DOI: https://doi.org/10.24022/1997-3187-2022-16-4-533-540

For citation: Stepanova N.M., Serguladze S.Yu., Sopov O.V., Aleksandrova S.A., Kvasha B.I. Intervention strategy in elderly patient with atrial fibrillation and severe left atrial fibrosis. Creative Cardiology. 2022; 16 (4): 533–40 (in Russ.). DOI: 10.24022/1997-3187-2022-16-4-533-540

Received / Accepted:  12.11.2022 / 14.12.2022

Keywords: atrial fibrillation radiofrequency ablation imaging high-density mapping fibrosis

Full text:  

 

Abstract

In the modern world, there is a significant increase in the prevalence of atrial fibrillation (AF) mostly due to the growth of average age of the population in developed countries. Approaches to the treatment of AF are diverse, the most effective at the moment are invasive catheter interventions. The number of AF ablation procedures has been growing exponentially in the last decade, and the indications for this procedure are increasingly expanding against the backdrop of a general trend in the aging of the population. Cardiologists do not refer elderly patients to interventional treatment due to the expectation of lower efficacy and a higher risk of complications compared to younger patients. In turn, few surgeons have experience working with this group of patients. However, modern methods of prehospital examination and intraoperative high-density mapping expand the approach to interventional treatment of this group of patients. The described clinical case touches upon the peculiarities of the catheter technique for the treatment of AF in an elderly patient with a high percentage of fibrotic changes in the left atrium.

References

  1. https://scardio.ru/content/Guidelines/2020/Clinic_rekom_FP_TP-unlocked.pdf (access date 22.11.2022)
  2. Krijthe B.P., Kunst A., Benjamin E.J., Lip G.Y., Franco O.H., Hofman A. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 2013; 34 (35): 2746–51. DOI: 10.1093/eurheartj/eht280
  3. Poole J.E., Bahnson T.D., Monahan K.H., Johnson G., Rostami H., Silverstein A.P. et al.; CABANA Investigators and ECG Rhythm Core Lab. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA Trial. J. Am. Coll. Cardiol. 2020; 75 (25): 3105–18. DOI: 10.1016/j.jacc.2020.04.065
  4. Turagam M.K., Musikantow D., Whang W., Koruth J.S., Miller M.A., Langan M.N. et al. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a metaanalysis of randomized clinical trials. JAMA Cardiol. 2021; 6 (6): 697–705. DOI: 10.1001/jamacardio.2021.0852
  5. Chen J., Hocini M., Larsen T.B., Proclemer A., Sciaraffia E., Blomström-Lundqvist C.; Scientific Initiative Committee, European Heart Rhythm Association. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey. Europace. 2015; 17 (2): 314–7. DOI: 10.1093/europace/euv010
  6. Moser J.M., Willems S., Andresen D., Brachmann J., Eckardt L., Hoffmann E. et al. Complication rates of catheter ablation of atrial fibrillation in patients aged ≥75 years versus <75 years-results from the German ablation registry. J. Cardiovasc. Electrophysiol. 2017; 28 (3): 258–65. DOI: 10.1111/jce.13142
  7. Petersen J., Vettorazzi E., Hakmi S., Alassar Y., Meyer C., Willems S. et al. Should concomitant surgical ablation for atrial fibrillation be performed in elderly patients? J. Thorac. Cardiovasc. Surg. 2021; 161 (5): 1816–23.e1. DOI: 10.1016/j.jtcvs. 2019.10.186
  8. Feldt J., Fink T., Metzner A. Catheter ablation in elderly patients: a review of current studies and pending questions. Curr. Opin. Cardiol. 2019; 34 (1): 29–34. DOI: 10.1097/HCO.0000000000000579
  9. Abugattas J.P., Iacopino S., Moran D., De Regibus V., Takarada K., Mugnai G. et al. Efficacy and safety of the second generation cryoballoon ablation for the treatment of paroxysmal atrial fibrillation in patients over 75 years: a comparison with a younger cohort. Europace. 2017; 19 (11): 1798–803. DOI: 10.1093/europace/eux023
  10. Willy K., Frommeyer G., Dechering D.G., Wasmer K., Höwel D., Welle S.S. et al. Outcome of catheter ablation in the very elderly-insights from a large matched analysis. Clin. Cardiol. 2020; 43 (12): 1423–7. DOI: 10.1002/clc.23455
  11. Golukhova E.Z., Gromova O.I., Bulaeva N.I., Arakelyan M.G. Mechanisms of arrhythmogenesis and risk factors for thromboembolic events in patients with atrial fibrillation without concomitant coronary and valvular heart disease. Annals of the Russian Academy of Medical Scienes. 2020; 75 (5): 523–31 (in Russ.). DOI: 10.15690/vramn1337
  12. Rivner H., Mitrani R.D., Goldberger J.J. Atrial myopathy underlying atrial fibrillation. Arrhythm. Electrophysiol. Rev. 2020; 9 (2): 61–70. DOI: 10.15420/aer.2020.13
  13. Chen Y.H., Lin H., Wang Q., Hou J.W., Li Y.G. Efficacy and safety of adjunctive substrate modification during pulmonary vein isolation for atrial fibrillation: a meta-analysis. Heart Lung Circ. 2020; 29 (3): 422–36. DOI: 10.1016/j.hlc. 2019.01.018
  14. Kircher S., Arya A., Altmann D., Rolf S., Bollmann A., Sommer P. et al. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study. Europace. 2018; 20 (11): 1766–75. DOI: 10.1093/europace/eux310
  15. Yamaguchi T., Tsuchiya T., Nakahara S., Fukui A., Nagamoto Y., Murotani K. et al. Efficacy of left atrial voltage-based catheter ablation of persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 2016; 27 (9): 1055–63. DOI: 10.1111/jce.13019

About Authors

  • Nadezhda M. Stepanova, Cardiologist; ORCID
  • Sergey Yu. Serguladze, Dr. Med. Sci., Professor, Head of Department, Cardiac Surgeon; ORCID
  • Oleg V. Sopov, Cand. Med. Sci., Сardiovascular Surgeon; ORCID
  • Svetlana A. Aleksandrova, Cand. Med. Sci., Senior Researcher; ORCID
  • Boris I. Kvasha, Cand. Med. Sci., Сardiovascular Surgeon; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery